
1. antimicrob agents chemother. 2019 jun 24;63(7). pii: e00536-19. doi:
10.1128/aac.00536-19. print 2019 jul.

polymorphisms plasmodium falciparum kelch 13 p. vivax kelch 12 genes in
parasites collected three south pacific countries prior extensive
exposure artemisinin combination therapies.

gresty k(1)(2), anderson k(1)(2), pasay c(1)(3), waters nc(4), cheng q(5)(2).

author information: 
(1)drug resistance diagnostic department, australian defence force malaria
and infectious disease institute, brisbane, australia.
(2)the army malaria institute laboratory, qimr-berghofer medical research
institute, brisbane, australia.
(3)clinical tropical medicine, qimr-berghofer medical research institute,
brisbane, australia.
(4)walter reed army institute research, silver spring, maryland, usa.
(5)drug resistance diagnostic department, australian defence force malaria
and infectious disease institute, brisbane, australia qin.cheng@defence.gov.au.

the south pacific countries solomon islands, vanuatu, papua new guinea (png) 
adopted artemisinin-based combination therapies (acts) 2008. examined kelch
13 kelch 12 genes parasites originating countries 
act introduction. four kelch 13 two kelch 12 novel sequence polymorphisms,
not associated artemisinin resistance, observed parasites from
solomon islands vanuatu. polymorphisms observed png parasites. the
findings provide useful baseline information.

copyright Â© 2019 american society microbiology.

doi: 10.1128/aac.00536-19 
pmcid: pmc6591608
pmid: 31036683  [indexed medline]

